Critically attained threshold of cerebral hypoperfusion: Can it cause Alzheimer's disease?

被引:74
作者
De la Torre, JC [1 ]
机构
[1] Univ Calif San Diego, Dept Neurosci MTF 0624, La Jolla, CA 92093 USA
来源
VASCULAR FACTORS IN ALZHEIMER'S DISEASE | 2000年 / 903卷
关键词
D O I
10.1111/j.1749-6632.2000.tb06394.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
After nearly a century of inquiry, the cause of sporadic Alzheimer's disease (AD) remains to be found, On the subject of AD pathogenesis, recent basic and clinical evidence strongly argues in favor of the concept that AD is linked to brain circulatory pathology, This concept, when viewed from many different medical disciplines and from close pre-morbid similarities to vascular dementia, assembles and hypothetically explains most of the key pathologic events associated with the development of AD. These pathologic events are triggered in AD by impaired cerebral perfusion originating in the microvasculature which affects the optimal delivery of glucose and oxygen and results in an energy metabolic breakdown or brain cell biosynthetic and synaptic pathways, We propose that two factors converge to initiate cognitive dysfunction and neurodegeneration as expressed in AD brain: (1) advanced aging, and (2) the presence of a condition that lowers cerebral perfusion. The first factor Introduces a normal but potentially deconstructing process that lowers cerebral blood now in proportion to increased aging, whereas the second Factor adds a crucial burden that further lowers brain perfusion to a critical threshold that triggers neuronal metabolic compromise. When age and a condition that lowers cerebral perfusion converge, critically attained threshold of cerebral hypoperfusion (CATCH) results. CATCH is a cyclical and progressive cerebrovascular insufficiency that will destabilize neurons, synapses, neurotransmission, and cognitive ability, eventually evolving into a neurodegenerative process characterized by the formation of senile plaques, neurofibrillary tangles, and amyloid angiopathy, The concept of impaired cerebral perfusion as the cause of this dementia also explains the heterogeneic profile observed in AD patients, because an extensive list of risk factors for AD are also reported to significantly diminish blood now to the aging brain.
引用
收藏
页码:424 / 436
页数:13
相关论文
共 63 条
  • [1] Abdollahian NP, 1998, CYTOCHROME OXIDASE IN NEURONAL METABOLISM AND ALZHEIMER'S DISEASE, P233
  • [2] Bartenstein P, 1997, J NUCL MED, V38, P1095
  • [3] THE FLUORODEOXYGLUCOSE F-18 SCAN IN ALZHEIMERS-DISEASE AND MULTI-INFARCT DEMENTIA
    BENSON, DF
    KUHL, DE
    HAWKINS, RA
    PHELPS, ME
    CUMMINGS, JL
    TSAI, SY
    [J]. ARCHIVES OF NEUROLOGY, 1983, 40 (12) : 711 - 714
  • [4] BLASS JP, 1993, NEUROLOGY, V43, pS25
  • [5] BOTET JP, 1992, STROKE, V23, P1556
  • [6] BUEE L, 1994, ACTA NEUROPATHOL, V87, P469
  • [7] Age related cognitive decline: A clinical entity? A longitudinal study of cerebral blood flow and memory performance
    Celsis, P
    Agniel, A
    Cardebat, D
    Demonet, JF
    Ousset, PJ
    Puel, M
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (06) : 601 - 608
  • [8] DIFFERENCES IN THE EFFECTS IN THE NEWBORN PIGLET OF VARIOUS NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON CEREBRAL BLOOD-FLOW BUT NOT ON CEREBROVASCULAR PROSTAGLANDINS
    CHEMTOB, S
    BEHARRY, K
    BARNA, T
    VARMA, DR
    ARANDA, JV
    [J]. PEDIATRIC RESEARCH, 1991, 30 (01) : 106 - 111
  • [9] Regional cerebral blood flow and cerebrovascular risk factors in the elderly population
    Claus, JJ
    Breteler, MMB
    Hasan, D
    Krenning, EP
    Bots, ML
    Grobbee, DE
    Van Swieten, JC
    Van Harskamp, F
    Hofman, A
    [J]. NEUROBIOLOGY OF AGING, 1998, 19 (01) : 57 - 64
  • [10] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21